Sermonix Pharma receives Chinese approval of IND application for lasofoxifene
08 Jun 2024 //
PHARMABIZ
Sermonix Announces Results of Phase 2 Study of Lasofoxifene vs. Fulvestrant
13 Sep 2022 //
GLOBENEWSWIRE
Sermonix to Present Poster on Phase 2 Study of Lasofoxifene in with Eli Lilly
04 Dec 2020 //
GLOBENEWSWIRE